At Pharma CI USA 2026, AI came up in nearly every conversation, but the bigger story was what leadership now expects from competitive intelligence. Here are the key takeaways on trust in AI, the rising value of primary intelligence, and why CI’s impact is increasingly measured by the decisions it shapes.
AI adoption in life sciences competitive intelligence nearly doubled in a single year. Our 2026 survey data shows where AI is delivering real impact, where friction is growing, and what CI leaders should realistically expect from their investment.
Benchmarking Wins Most companies still treat benchmarking as an annual ritual, usually tied to budget season, but the leaders are moving fast and gaining an advantage with Continuous Benchmarking. Instead of updating a static scorecard once a quarter, cutting edge companies are building real-time benchmarking engines powered by AI integrations and automation. Why? Because operations evolve daily. Luckily, we have …
Sales leaders don’t lack competitive information, they lack a system for capturing the intelligence that already exists in every rep conversation. This piece breaks down how field signal, if collected continuously, becomes a strategic asset rather than an anecdote traded at the next sales meeting.
Sales battlecards are built once and go stale fast, leaving reps to repeat outdated claims a buyer has already heard corrected. This guide breaks down what it takes to replace a static enablement program with a continuous system: sourcing field intelligence, validating it, and delivering it to reps before their next competitive deal.
Every competitive strategy has blind spots, but the organizations that identify them first gain a lasting advantage. Learn the most common sources of strategic risk and how continuous competitive monitoring can help uncover emerging threats before they impact growth, revenue, and market position.
Your sales, service, and product teams see market shifts every day, but that knowledge rarely reaches leadership in a usable form. FieldForce captures, validates, and translates frontline insight into decision-ready intelligence, helping commercial leaders spot competitive threats earlier, uncover growth opportunities faster, and align teams around a shared view of the market.
Most pharma CI teams attend the major congresses. Few are structured to capture everything those congresses offer. This post breaks down the five most common intelligence gaps, and what a well-designed coverage program does to close them.
Competitive intelligence creates value only when it leads to action. Discover how strategy teams can cut through information overload, identify the signals that matter, and turn market insights into faster decisions, stronger alignment, and sustainable competitive advantage.
Most pricing strategies look strong on paper. But without deal governance, small concessions accumulate and exceptions become the norm. Here is how commercial deal discipline keeps your pricing strategy intact where it matters most: in the field.
